Ligand Pharmaceuticals Inc (LGND)

Operating Cash Flow Growth

52.04%

Quarterly · Period ending:

LGND logo

LGND Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported52.04%
LGND Quarterly Cash from Operations YoY % (-3.57% → 52.04%)
High-resolution chart · PNG

LGND operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
52.0415%
290.8254%
61.02%
-64.1664%
18.6495%
-236.5149%
300.0984%
377.7662%
16,336.5854%
-44.9423%
-86.6921%
-62.6824%
-100.6904%
-34.7292%
93.4448%
2.3171%
-41.7088%
383.6433%
5,047.486%
57.1204%
-16.4261%
-36.4496%
107.3171%
305.664%
139.9325%
-62.6099%
-122.5316%
-122.8824%
-182.9097%
-25.5147%
4.0307%
-2.0542%
609.0699%
150.8505%
49.145%
49.2739%
0.1446%
84.7034%
53.6261%
77.4744%
3.2351%
73.0307%
33.3691%
179.4378%
150.6487%
194.1017%
-14.8579%
1,140.39%
-42.2229%
24.0135%
454.0516%
60.5495%
1,047.6776%
663.1436%
-69.0466%
13.7441%
90.9012%
-140.5049%
639.7692%
86.2523%
-262.8778%
105.7382%
-0.8534%
32.334%
-175.1525%
34.1818%
-120.8138%
15.6678%
174.2886%
-156.6337%
170.4791%
5.5021%
86.4748%
79.2741%
89.5479%
49.2131%
-355.4056%
-126.9265%
-796.3966%
-512.3767%
18.444%
-669.5033%
-56.9472%
196.6022%
32.0643%
28.1803%
205.5798%
-169.3987%
-436.6898%
62.9014%
195.9632%
25.9501%
129.0836%
-6,812.766%
-175.4826%
49.3099%
-424.4062%
98.9271%
62.0656%
55.3645%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.